MentionFox
Home › funding signals › Kopra Bio
Accelerator · announced

Kopra Bio (YC S24) — Genetically engineered viruses that teach your immune system to kill…

Kopra Bio makes genetically engineered viruses that teach your immune system to kill cancer using tech we developed at UCSF. We’re making the next Keytruda ($25B/yr cancer drug blockbuster) starting with the most aggressive form of brain cancer, glioblastoma.

Kopra Bio is a Y Combinator company in the Summer 2024 batch. Its directory entry describes it as: Genetically engineered viruses that teach your immune system to kill…. The founder listed is Alexander Haddad (Founder) (Y Combinator directory entry, August 20, 2024).

6 more companies from YC Summer 2024 ↓

Run the free check on Kopra Bio →

Sell to companies like Kopra Bio? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Kopra Bio

New accelerator entry · 2024-08-20 · the record

Summer 2024
batch
2
people
Early
stage
United States of America
region
Open the record →

What the record says

BatchSummer 2024
Announced2024-08-20
StageEarly
StatusActive
Team size2
IndustryHealthcare
Sub-industryHealthcare -> Therapeutics
SectorsGene Therapy, Synthetic Biology, Biotech, Therapeutics, Oncology
RegionsUnited States of America, America / Canada, Remote, Partly Remote
BasedSan Francisco, CA, USA
HiringNo
Sitehttps://kopra.bio
Founded2024
YC group partnerAnkit Gupta
Previously known asGlioTx

Pitching, partnering or investing alongside them? See who really runs and owns Kopra Bio.

Free to see. No signup.

Keep reading

More on Kopra Bio and the records around it.

Also in YC Summer 2024

Same batch, Healthcare first.

What do you want to do with Kopra Bio?

Get the full cited report on Kopra Bio

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Kopra Bio: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

In their words

Kopra Bio makes genetically engineered viruses that teach your immune system to kill cancer using tech we developed at UCSF. We’re making the next Keytruda ($25B/yr cancer drug blockbuster) starting with the most aggressive form of brain cancer, glioblastoma. In the most challenging brain cancer model, we improve survival from 0% with the current FDA approved treatment to 90% with our treatment.

Want the whole picture on Kopra Bio?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Kopra Bio: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Kopra Bio covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Kopra Bio: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.

Sourced from the company's Y Combinator directory entry.

RSS

Tools for this story

Each opens in a new tab, filled in for Kopra Bio. With no account yet, you sign up free and land on the result.

On these startup lists

Biotech startups

Share this page

Is this your company?

Share the news. Sharing needs no account.

Kopra Bio: Accepted into Y Combinator Summer 2024
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/yc-kopra-bio
Last updated 2026-10-29
Primary record: Y Combinator directory entry
Kopra Bio (YC S24) — Genetically engineered viruses that teach your immune system to kill…. MentionFox, 2026-10-29. https://mentionfox.com/funding/yc-kopra-bio